Trials / Completed
CompletedNCT02166398
A Randomized, Open-label, Single Dose, Two-way Crossover Clinical Trial to Compare the Safety, Pharmacokinetic Profiles of UI15AML055MT and Amosartan® Tablet 5/50 mg After a Single Oral Administration in Healthy Male Volunteers
Phase 1 Study of Compare the Safety, Pharmacokinetic Profiles of UI15AML055MT and Amosartan® Tablet 5/50 mg
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 46 (estimated)
- Sponsor
- Korea United Pharm. Inc. · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
A randomized, open-label, single dose, two-way crossover clinical trial to compare the safety, pharmacokinetic profiles of UI15AML055MT and Amosartan® tablet 5/50 mg after a single oral administration in healthy male volunteers
Detailed description
A randomized, open-label, single dose, two-way crossover clinical trial to compare the safety, pharmacokinetic profiles of UI15AML055MT and Amosartan® tablet 5/50 mg after a single oral administration in healthy male volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | UI15AML055MT | tab, PO |
| DRUG | Amosartan 5/50 | tab, PO |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2014-10-01
- Completion
- 2014-12-01
- First posted
- 2014-06-18
- Last updated
- 2015-06-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02166398. Inclusion in this directory is not an endorsement.